GenMark Diagnostics Schedules First Quarter 2017 Financial Results Conference Call for May 2, 2017
April 18 2017 - 8:40PM
Business Wire
GenMark Diagnostics, Inc. (NASDAQ:GNMK) today announced that it
plans to release its first quarter earnings results after market
close on Tuesday, May 2, 2017. Management will hold a conference
call to review the Company's financial performance starting at 4:30
p.m. ET on the same day. The conference call will be concurrently
webcast. The link to the webcast will be available on the GenMark
Diagnostics, Inc. website at www.genmarkdx.com under the investor
relations section and will be archived for future reference. To
listen to the conference call, please dial (877) 312-5847
(US/Canada) or (253) 237-1154 (International) and use the
conference ID number 51141106 approximately five minutes prior to
the start time.
ABOUT GENMARK DIAGNOSTICS
GenMark Diagnostics (NASDAQ: GNMK) is a leading provider of
automated, multiplex molecular diagnostic testing systems that
detect and measure DNA and RNA targets to diagnose disease and
optimize patient treatment. Utilizing GenMark’s proprietary
eSensor® detection technology, GenMark’s eSensor XT-8® system is
designed to support a broad range of molecular diagnostic tests
with a compact, easy-to-use workstation and self-contained,
disposable test cartridges. The eSensor detection technology is
also incorporated into GenMark’s sample-to-answer system, ePlex®.
For more information, visit www.genmarkdx.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170418006673/en/
GenMark Diagnostics, Inc.Hany Massarany,
760-448-4325President/Chief Executive Officer
GenMark Diagnostics (NASDAQ:GNMK)
Historical Stock Chart
From Mar 2024 to Apr 2024
GenMark Diagnostics (NASDAQ:GNMK)
Historical Stock Chart
From Apr 2023 to Apr 2024